BostonGene Corp.

Industry

  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
    • Drug Discovery Technologies
      • Genomics-Proteomics
      • Bioinformatics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
    • Vaccines
  • Digital Health
    • Artificial Intelligence
See more in Biomedtracker

Latest on BostonGene Corp.

Scrip

Asia Deal Watch: Ocumension Obtains Chinese Rights To Eight Alcon Products

 
• By Joseph Haas, Dexter Jie Yan, Vibha Ravi, and Anju Ghangurde

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. OcuMension Signs Stock-for-Rights

Scrip

LegoChem Brings Late Christmas Cheer With $1.7bn ADC Deal

 
• By Jung Won Shin

More signs of improvement in South Korean biopharma alliances emerged right at the end of 2023, with LegoChem Biosciences, Inc. announcing an up to $1.7bn antibody-drug conjugate (ADC) deal with Ja

In Vivo

Financing Quarterly Statistics, Q2 2022

 
• By Deanna Kamienski and Maureen Riordan

Biopharma financings during the second quarter of 2022 reached $12.5bn. The largest was by Blueprint Medicines Corporation (precision therapies for cancer and blood disorders) through an arrangement

Scrip

Tech Transfer: BMS, Evotec Partner With Four UK Universities On Translational Research Efforts

 
• By Joseph Haas and John Davis

Bristol, Evotec Tap Researchers In Birmingham, Edinburgh, Nottingham, Dundee Evotec SE and Bristol Myers Squibb Company will collaborate with researchers at four UK universities on identifying pot